Neurodegeneration
Does brain region loss predict memory decline in Parkinson's?
Open access · cc by · source: Europe PMC
Damage to a specific brain region called the nucleus basalis of Meynert can predict whether a person with Parkinson's disease will develop cognitive decline.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Degeneration of subcortical grey matter structures, such as the caudate, hippocampus, and the nucleus basalis of Meynert, is closely linked to and can predict the onset of cognitive impairment in patients with Parkinson's disease.
Evidence for the claim as stated.
Microstructural alterations in brain tissue, including changes in tissue diffusivity, can precede and predict future cognitive decline in neurodegenerative diseases.
Evidence for the claim as stated.
Microstructural degeneration measured via tissue diffusivity can serve as a stronger longitudinal predictor of cognitive decline than macroscopic grey matter loss alone.
Evidence for the claim as stated.
Study at a glance
- Design
- Cohort — Drug-naïve PD vs controls; nucleus basalis volume/DTI predicting later cognitive decline
- N
- N=471 · 304 drug-naïve PD and 167 healthy controls at baseline; DTI subset n = 84 PD
- Population
- Drug-naïve Parkinson's disease patients and healthy controls
- Outcome
- Nucleus basalis of Meynert degeneration as a predictor of later cognitive impairment in PD
Structured fields used in claim comparison tables when every cited study has a complete layer.
Inspect source passages
Does brain region loss predict memory decline in Parkinson's?
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
304 drug-naive patients with Parkinson's disease analyzed at baseline
A total of 304 patients with Parkinson’s disease not on Parkinson’s medications (drug-naïve) and 167 healthy control subjects were identified.
62 healthy controls in the DTI subset analysis
DTI analysis was done on a subset of 62 healthy controls and 84 patients with Parkinson’s disease (B).
Key findings
They found that patients with Parkinson's disease who had cognitive impairment at baseline had lower grey matter volume and higher tissue diffusivity in the nucleus basalis of Meynert. In the longitudinal analysis, structural and microstructural degeneration of the nucleus basalis of Meynert predicted who would develop cognitive impairment over the 36-month period. Specifically, microstructural changes were a stronger predictor of cognitive decline than structural grey matter loss alone.
Methodology
The researchers analyzed MRI data from 304 drug-naive patients with Parkinson's disease and 167 healthy control subjects. To evaluate brain structure, they measured grey matter volume and assessed tissue microstructure with diffusion tensor imaging in a subset of 84 patients and 62 controls. They monitored patients' cognitive status every 6 months for up to 36 months to see who developed cognitive impairment.
Limitations
Because the study relies on database neuroimaging, it cannot definitively prove a causal biological mechanism without direct post-mortem tissue examination. Additionally, the study does not clarify exactly when degeneration of this brain region begins, nor does it address how this timeline relates to other types of dementia. Lastly, the diffusion tensor imaging analysis was restricted to a smaller subset of patients, which might limit the generalizability of these specific predictive values.
Related papers in this topic
Same topic cluster — not a recommendation engine.
- How tau buildup shapes brain networks in dementia
- How does brain structure change in early Parkinson's disease?
- How does brain inflammation affect connectivity and thinking in AD?
- Can a new PET imaging tracer distinguish different tau diseases?
- Using Brain Scans to Predict Cognitive Decline in Alzheimer's